Lack of increased expression of cell surface markers for circulating fibrocyte progenitors in limited scleroderma

Clinical Rheumatology

Volumn 26, Issue 7, 2007, Pages 1136-1141

  Russo, R ^a   Medbury, H ^a   Guiffre, A ^a   Englert, H ^a   Manolios, Nick ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

CREST syndrome; Fibrocytes; Limited scleroderma; Monocytes; Progenitor cells

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; CD34 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE MARKER; FC RECEPTOR; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL SURFACE; CELL TRANSFORMATION; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LIMITED SCLERODERMA; MALE; MONOCYTE; PATHOGENESIS; PILOT STUDY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HUMANS; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; MONOCYTES; SCLERODERMA, LIMITED;

EID: 34249885583     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0461-5     Document Type: Article

References (11)

1. LeRoy EC, Black C, Fleishmajer R et al (1998) Scleroderma (systemic sclerosis): Classification, subsets, and pathogenesis. J Rheumatol 15:202-205
2. Douvas A (1996) Pathogenesis: Serologic correlates. In: Clements PJ, Furst DE (eds) Systemic sclerosis. Williams and Wilkins, Baltimore, pp 175-202
3. White B (1996) Pathogenesis: Serologic correlates. In: Clements PJ, Furst DE (eds) Systemic sclerosis. Williams and Wilkins, Baltimore, pp 229-250
4. LeRoy EC, McGuire M, Chen N (1974) Increased collagen synthesis by scleroderma fibroblasts in vitro. A possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 54:880-889
5. Bucala R, Spiegal LA, Chesney J, Hogan M, Cerami A (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1:71
6. Abe R, Donnelly S, Peng T, Bucala R, Metz C (2001) Peropheral blood fibrocytes: Differentiation pathway and migration to wound sites. J Immunol 166:7556-7562
7. Aiba S, Tabata N, Ohtani H, Tagami H (1994) CD34+ spindle-shaped cells selectively disappear from the skin lesions of scleroderma. Arch Dermatol 130:593-597
8. The Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
9. Hauser C, Kaya G, Chizzolini C (2004) Nephrogenic fibrosing dermopathy in a renal transplant recipient with tubulointerstitial nephritis and uveitis. Dermatology 209:50-52
10. Cowper S, Su L, Bhawan J, Robin H, LeBoit PE (2001) Nephrogenic fibrosing dermopathy. Am J Dermatopathol 23(5):383-393
11. Pilling D, Buckley CD, Salmon M, Gomer R (2003) Inhibition of fibrocyte differentiation by serum Amyloid P. J Immunol 171(10):5537-5546